# Clinical outcomes in hospitalized patients with community-acquired pneumonia: A comprehensive analysis of associated factors

**Authors:** Deema Rahme, Hania Nakkash Chmaisse, Pascale Salameh

PMC · DOI: 10.1371/journal.pone.0344171 · 2026-03-05

## TL;DR

This study in Lebanon finds that inappropriate antibiotic use and certain patient factors worsen outcomes for hospitalized pneumonia patients.

## Contribution

The study identifies specific factors, including antibiotic prescribing practices, that predict poor outcomes in CAP patients in Lebanon.

## Key findings

- Inappropriate antibiotic selection and dosing were strongly linked to poor clinical outcomes.
- Advanced age and comorbidities like heart failure and coronary disease predicted worse outcomes.
- Classical CAP symptoms were associated with better clinical outcomes.

## Abstract

Community-acquired pneumonia (CAP) remains a significant cause of hospitalization and mortality globally. Optimizing clinical outcomes in CAP depends heavily on timely, appropriate empiric antibiotic therapy. However, limited data from low- and middle-income countries hinder effective stewardship efforts. The study aims to assess clinical outcomes among hospitalized CAP patients in Lebanon and identify key factors associated with deterioration or death, with particular emphasis on the role of guideline-concordant empiric antibiotic prescribing.

A cross-sectional study was conducted in five tertiary hospitals across Lebanon between January and June 2024. Adult patients admitted with CAP were included. Demographic, clinical, laboratory, microbiological, and treatment data were extracted. Antibiotic regimens were evaluated for adherence to national CAP guidelines. Multivariable logistic regression was used to identify predictors of poor clinical outcomes, defined as ICU admission or in-hospital death.

Inappropriate antibiotic selection (aOR=18.81, p<0.001) and dosing (aOR=1.78, p=0.027) were significantly associated with poor outcomes. Additional predictors included advanced age, congestive heart failure, coronary artery disease, elevated WBC, and CURB-65 scores ≥3. Conversely, patients with classical CAP presentations (e.g., wheezing, rales) were more likely to experience favorable outcomes.

Inappropriate empiric antibiotic prescribing significantly worsens clinical outcomes in hospitalized CAP patients. These findings underscore the urgent need for strengthening antimicrobial stewardship programs, implementing clinical decision support tools, and reinforcing physician education to promote adherence to national guidelines and improve patient safety.

## Linked entities

- **Diseases:** congestive heart failure (MONDO:0005009), coronary artery disease (MONDO:0005010)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** leukocytosis (MESH:D007964), cough (MESH:D003371), diabetes (MESH:D003920), atrial fibrillation (MESH:D001281), COVID-19 (MESH:D000086382), lung disease (MESH:D008171), AMR (MESH:D060467), myocardial infarction (MESH:D009203), SIRS (MESH:D018746), infection (MESH:D007239), bronchitis (MESH:D001991), cardiovascular disease (MESH:D002318), dyspnea (MESH:D004417), hypertension (MESH:D006973), pneumococcal diseases (MESH:D011008), dyslipidemia (MESH:D050171), death (MESH:D003643), critically ill (MESH:D016638), respiratory tract infections (MESH:D012141), anemia (MESH:D000740), inflammatory (MESH:D007249), sepsis (MESH:D018805), Infectious Diseases (MESH:D003141), CAP (MESH:D003147), respiratory distress (MESH:D012128), cystitis (MESH:D003556), coronary artery disease (MESH:D003324), allergy (MESH:D004342), heart disease (MESH:D006331), pneumonia (MESH:D011014), confusion (MESH:D003221), COPD (MESH:D029424), organ failure (MESH:D009102), congestive heart failure (MESH:D006333), wheezing (MESH:D012135), Renal impairment (MESH:D007674)
- **Chemicals:** fluoroquinolone (MESH:D024841), ciprofloxacin (MESH:D002939), macrolide (MESH:D018942), oxygen (MESH:D010100), penicillin (MESH:D010406), Aminoglycoside (MESH:D000617), RFQ (-), beta-lactam (MESH:D047090), AG (MESH:D012834), levofloxacin (MESH:D064704), carbapenem (MESH:D015780)
- **Species:** Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287], Streptococcus pneumoniae (species) [taxon 1313]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962476/full.md

---
Source: https://tomesphere.com/paper/PMC12962476